explore -WSS

explore

author：leisure time 2025-09-27 23:02:14 - browse：1446

glum Benjamin — health insurance coverage from STAT — Adobe

Three biotech VC veterans, including one of the co-founders of radiopharma success story RayzeBio, are launching a new investment fund called Scion Life Sciences.

Scion was started by former Apple Tree Partners colleagues Sam Hall and Aaron Kantoff, along with Tadd Wessel, managing partner of the health care private equity firm Petrichor. They raised $310 million for its first fund, blowing past their original $250 million target.

They’re planning on taking a different tack with biotech venture capital. For starters, Scion plans to work on a significantly longer timeframe. Most firms in existence today write checks, help investments grow, and find a way to recoup their money in a 10-year timeframe. Scion is doubling that, setting a 20-year plan for its first fund.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： New Alzheimer's drugs heat up race for early detection blood tests

Wikipedia

WSS

The SUPPORT Act is critical to fighting the opioid crisis

GSK to buy asthma

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Risky weight loss products often used by teens globally, per study

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

New lawsuit accuses health insurer Cigna of denying claims in bulk

leisure time

explore

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Readout LOUD podcast: live from JPM 2024

Duchenne breakthrough therapy leaves behind pioneering families

Risky weight loss products often used by teens globally, per study

Walensky prepares to leave CDC — and Congress — behind

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Bright Health sells Medicare Advantage business to Molina

Risky weight loss products often used by teens globally, per study

Hepatitis C has a cure — but many Americans still lack access to it

As JPM 2024 winds down, some health tech firms project optimism

focus

Caregivers of transplant patients call for more support, training

JPM 2024: Nvidia claims we're in biological revolution. Are we?

As JPM 2024 winds down, some health tech firms project optimism

The haunting brain science of long Covid

Why patients can’t get everything they want on drug pricing

Former reverend arrested for allegedly killing 8

entertainment

explore

Wikipedia

focus